CADMD Stock Price, News & Analysis
Company Description
CADMD (OTC: CADMD) is a publicly traded drug manufacturers—specialty & generic company in the Healthcare sector. The company has a market capitalization of $2.7M.
CADMD stock has gained 60.0% over the past year.
This page provides a comprehensive overview of CADMD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
CADMD (CADMD) stock. Over the past 12 months, the stock has gained 60.0%. At a market capitalization of $2.7M, CADMD is classified as a micro-cap stock with approximately 33.4M shares outstanding.
Latest News
CADMD has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. View all CADMD news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CADMD Company Profile & Sector Positioning
CADMD (CADMD) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing CADMD often look at related companies in the same sector, including (ATNX), (CADMF), Mallinckrodt Plc (MNKKQ), CHINA INFRASTRUCTURE CONSTRUCTI (CHNC), and Vencanna Ventures (TPPRF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CADMD's relative position within its industry.